BALVERSA® is a prescription medicine used to treat adults with bladder cancer (urothelial cancer) that has spread or cannot be removed by surgery:
- which has a certain type of abnormal FGFR gene, and
- who have tried at least one other medicine by mouth or injection (systemic therapy) that did not work or is no longer working.
Your healthcare provider will test your cancer for certain types of abnormal FGFR genes and make sure that BALVERSA® is right for you.
BALVERSA® is not recommended for the treatment of people who are eligible for and have not received prior PD-1 or PD-L1 inhibitor therapy.
It is not known if BALVERSA® is safe and effective in children.